Research Firm with a Qualitative Overlay, Pearl Gray Equity and Research

Pearl Gray Equity and Research

Research Firm with a Qualitative Overlay

Quantitative fund & research firm with a qualitative overlay. 

Our coverage: General U.S. with a skew towards the primary sector. 

Methods: Smart Beta/Factor Pricing, Neural Networks, Street Gossip, and Common Sense.

Equity Bottom-Up

<ul>
<li>Elevance Health, Inc. has been active in the M&amp;A market with the divestiture of its life disability business and a "new markets" acquisition.</li>
<li>However, evidence suggests that success is not guaranteed, according to the company.</li>
<li>The company's stock has been downgraded to a moderate buy.</li>
</ul>


Elevance Health, Inc. has been active in the M&amp;A market with the divestiture of its life disability business and a "new markets" acquisition.
However, evidence suggests that success is not guaranteed, according to the company.
The company's stock has been downgraded to a moderate buy.


Elevance Health: A Critical Update (Rating Downgrade)

United States

Elevance Health, Inc. operates as a health benefits company. The Company provides health, dental and vision, and pharmacy benefits, as well as life insurance, and life and disability insurance benefits. Elevance Health offers a broad spectrum of network-based managed care plans to large and small employer, individual, medicaid, and medicare markets.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Elevance Health (ELV US)

Elevance Health: A Critical Update (Rating Downgrade)

Elevance Health, Inc. has been active in the M&A market with the divestiture of its life disability business and a "new markets" acquisition.

Pearl Gray Equity and Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)